Neurolixis Inc. announced today that it has established a subsidiary in France. The main purpose of the subsidiary is to facilitate interaction with European biotechnology, pharmaceutical research and development and investment communities. The subsidiary, Neurolixis SAS, is based at a 'start-up incubator' in Castres, near the regional center of Toulouse. Neurolixis SAS will provide the contact point for collaborations with researchers at several European academic institutions.

Read the full press announcement: .


Please enable the javascript to submit this form

Follow Neurolixis on: